Nalini Singh
Rajendra Institute of Medical Sciences(IN)
Publications by Year
Research Areas
CRISPR and Genetic Engineering, Pneumocystis jirovecii pneumonia detection and treatment, Tuberculosis Research and Epidemiology, Mesenchymal stem cell research, Lymphoma Diagnosis and Treatment
Most-Cited Works
- → High treatment success rate for multidrug-resistant and extensively drug-resistant tuberculosis using a bedaquiline-containing treatment regimen(2018)130 cited
- → Towards host-directed therapies for tuberculosis(2015)127 cited
- → Human mesenchymal stem cells (hMSCs) expressing truncated soluble vascular endothelial growth factor receptor (tsFlk‐1) following lentiviral‐mediated gene transfer inhibit growth of Burkitt's lymphoma in a murine model(2005)49 cited
- → POSITIVE CORRELATION BETWEEN APOPTOTIC AND PROLIFERATIVE INDICES IN GASTROINTESTINAL LYMPHOMAS OF MUCOSA-ASSOCIATED LYMPHOID TISSUE (MALT)(1996)46 cited
- → Surgical Treatment of Complications of Pulmonary Tuberculosis, including Drug-Resistant Tuberculosis(2015)43 cited
- → Cellular therapy in Tuberculosis(2015)31 cited
- → Continuous delivery of human type I interferons (α/β) has significant activity against acute myeloid leukemia cells in vitro and in a xenograft model(2006)29 cited
- → Molecular Docking for Prediction and Interpretation of Adverse Drug Reactions(2018)22 cited
- → Risk of Nephrotoxicity in Patients With Drug-Resistant Tuberculosis Treated With Kanamycin/Capreomycin With or Without Concomitant Use of Tenofovir-Containing Antiretroviral Therapy(2018)14 cited
- → Mislocalization of BRCA1-complex due to ABRAXAS Arg361Gln mutation(2014)2 cited